Companion Diagnostics

Leverage the expertise behind one of the most successful companion diagnostics on the market to advance your companion diagnostic programs

• Prototype test development (e.g. PD-L1 assay for lung carcinoma clinical study) 
• Expert consultation for:

- Optimal antibody selection
- Appropriate scoring scheme
- Pivotal cut-off decisions
- Strategy for testing & commercialization

• Prospective testing of clinical samples (CLIA)
• Accumulation of pivotal data
• Validation reports for inclusion in regulatory filings
• Logical & cost-effective approach